Integrated Use of Minimal Residual Disease Classification and IKZF1 Alteration Status Accurately Predicts 79% of Relapses In Pediatric Acute Lymphoblastic Leukemia

被引：0
|
作者：
Waanders, Esme [1 ]
van der Velden, Vincent H. J. [2 ]
van der Schoot, Ellen [3 ,4 ]
van Leeuwen, Frank N.
van Reijmersdal, Simon V. [1 ]
de Haas, Valerie [5 ]
Veerman, Anjo J. [6 ]
van Kessel, Ad Geurts [1 ]
Hoogerbrugge, Peter M.
Kuiper, Roland P. [1 ]
van Dongen, Jacques J. M. [2 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands
[2] Erasmus Univ, Dept Immunol, Med Ctr Rotterdam, NL-3000 DR Rotterdam, Netherlands
[3] Sanquin Res, Expt Immunohematol, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[5] DCOG, The Hague, Netherlands
[6] Vrije Univ Amsterdam Med Ctr, Dept Paediat Oncol, Amsterdam, Netherlands
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [21] Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia
    Campana, Dario
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (05) : 1083 - +
  • [22] Application of minimal residual disease monitoring in pediatric patients with acute lymphoblastic leukemia
    Qin, X.
    Zhang, M-Y
    Liu, W-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (20) : 6885 - 6895
  • [23] The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia
    Xue, Yu-juan
    Wang, Yu
    Jia, Yue-ping
    Zuo, Ying-xi
    Wu, Jun
    Lu, Ai-dong
    Zhang, Le-ping
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (04) : 547 - 555
  • [24] The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia
    Yu-juan Xue
    Yu Wang
    Yue-ping Jia
    Ying-xi Zuo
    Jun Wu
    Ai-dong Lu
    Le-ping Zhang
    International Journal of Hematology, 2021, 113 : 547 - 555
  • [25] MITOCHONDRIAL DNA AND MINIMAL RESIDUAL DISEASE ASSESSMENT IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Villanueva, N.
    Agsalda, M.
    Chang, L.
    Ernst, T.
    Saito, A.
    Pritchett, L.
    Shiramizu, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (01) : 184 - 184
  • [26] Minimal Residual Disease in Pediatric Precursor-B Acute Lymphoblastic Leukemia
    Naithani, Rahul
    INDIAN PEDIATRICS, 2016, 53 (12) : 1063 - 1064
  • [27] IKZF1 Status As an Independent Prognostic Marker in Adult Common B-Cell Acute Lymphoblastic Leukemia
    Yao, Qiumei
    Liu, Kaiyan
    Jiang, Bing
    Liu, Yanrong
    Jiang, Qian
    Jiang, Hao
    Zhang, Xiaohui
    Chen, Shanshan
    Huang, Xiaojun
    Xu, Lanping
    Ruan, Guorui
    BLOOD, 2014, 124 (21)
  • [28] IKZF1 (IKAROS) deletions as a marker of minimal residual disease in patients with acute leukaemia after alloBMT
    Barkhatov, I.
    Zagrivnaya, M.
    Akimova, A.
    Semenova, E.
    Zubarovskaya, L.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S262 - S263
  • [29] Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia
    Mullighan, Charles G.
    Su, Xiaoping
    Zhang, Jinghui
    Radtke, Ina
    Phillips, Letha A.
    Miller, Christopher B.
    Ma, Jing
    Liu, Wei
    Cheng, Cheng
    Harvey, Richard C.
    Chen, I-Ming
    Clifford, Robert
    Carroll, William L.
    Reaman, Gregory
    Devidas, Meenakshi
    Gerhard, Daniela S.
    Yang, Wenjian
    Bowman, W. Paul
    Shurtleff, Sheila A.
    Relling, Mary V.
    Smith, Malcolm
    Hunger, Stephen P.
    Willman, Cheryl L.
    Downing, James R.
    BLOOD, 2008, 112 (11) : 163 - 163
  • [30] Minimal residual disease in childhood acute lymphoblastic leukemia: Current status and challenges
    Izraeli, S
    Waldman, D
    ACTA HAEMATOLOGICA, 2004, 112 (1-2) : 34 - 39
12345